Award
Delivery Order #SPE2DR26FGAW4
DMS Pharmaceutical Group Awarded Delivery Order for NEXPLANON Implants
Buyer
Defense Logistics Agency
Award Amount
$20,115.36
Ceiling
$20,115.36
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Mar 19, 2026
Identifier
SPE2DR26FGAW4
NAICS
424210
This award represents a delivery order under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a reputable provider specializing in high-quality healthcare and pharmaceutical products. The specific procurement involves NEXPLANON 68 mg implants, a critical pharmaceutical product used in reproductive health. This delivery order contributes significantly to the agency's capability to ensure timely access to essential medications within healthcare settings. The scope of work includes the provision and delivery of these implants to a specified location in Park Ridge, Illinois, supporting ongoing medical treatment programs. The contract was issued as a delivery order within a pre-established agreement, thus bypassing a new competitive bidding process. Scheduled for a short-term period in early 2026, this contract reflects an ongoing commitment to maintaining effective pharmaceutical supply chains for public health needs.
Description
4571044813!NEXPLANON 68 MG IMPLANTS